Joshua Fleishman

Joshua Fleishman is a Pharm.D. candidate at St. John's University and is a Pharmaceutical Scientist at Stellate Therapeutics, a pre-clinical biotech focused on developing microbiome-derived small molecules to treat neurodegenerative diseases. A Pharm.D. candidate with a unique multi-disciplinary toolkit, he uses his expertise in molecular pharmacology, medicinal chemistry, biochemistry, bioinformatics, pharmaceutics, clinical therapeutics, and mathematical modeling to spearhead drug discovery/development projects. Joshua has also worked for over half a decade to provide inclusive, intuition-based learning services for students within STEM disciplines and thinks deeply about how clinical development can build equitable, safe, and effective patient-centered care.